Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005–2020
Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026-06 · 66 (3)
DOI: 10.1111/ajo.70157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, online erschienen am 17.06.2026. Verfasst von Sarah Donald und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health - Dunedin, Faculty of Medicine, University of Otago - Ōtākou Whakaihu Waka, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Antiemetics, Practice Patterns, Physicians', Pregnancy Complications. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Research Council of New Zealand.
Abstract (Originalsprache)
Background
Antiemetic use during pregnancy is rising in high‐income countries. Increasing use of antiemetics has also been documented in Aotearoa New Zealand (NZ); however, the specific antiemetics dispensed have not been reported.
Aim
To describe patterns of antiemetic dispensing during pregnancy in NZ, 2005–2020. Materials and Methods Community‐based antiemetic dispensings were linked with 1.37 million pregnancies in the New Zealand Pregnancy Cohort. The proportions of pregnancies in which there was at least one dispensing of any and of specific antiemetics were calculated for each trimester and calendar year. Maternal characteristics and the sequence in which unique antiemetic regimens were introduced were described for pregnancies with first trimester exposure.
Results
First trimester antiemetic exposure increased from 4.1% to 19.7% of pregnancies between 2005 and 2019. Although metoclopramide was the most commonly dispensed antiemetic during Trimester 1 in all years (increasing from 3.1% to 12.4%), there was a substantial increase in ondansetron dispensing (0.1% to 9.1%). Ondansetron users were more likely than metoclopramide users to be European/Other and have a hospital admission for hyperemesis gravidarum. Metoclopramide and ondansetron monotherapy were first‐line regimens in 70.0% and 1.9% of pregnancies with Trimester 1 exposure between 2005 and 2010 versus 46.5% and 26.5% between 2016 and 2020.
Conclusions
Ondansetron dispensing increased substantially over time. Further exploration of the context of ondansetron prescribing in NZ is warranted, as is further research into potential adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Public Health - Dunedin, Faculty of Medicine, University of Otago - Ōtākou Whakaihu Waka, Dunedin, New Zealand.
- Department of Mathematics and Statistics, University of Otago - Ōtākou Whakaihu Waka, Dunedin, New Zealand.
- Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.
- Te Whatu Ora Waitematā, Auckland, New Zealand.
- Te Whatu Ora Southern, Dunedin, New Zealand.
- Te Whatu Ora Southern, Invercargill, New Zealand.
ORCID-Profile: Sarah Donald, Katrina Sharples, Dave Barson, Michael Stitely, Lianne Parkin
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Donald, S., Sharples, K., Barson, D., Maclennan, K., Te Karu, L., Phone, D., van Asten, H., Stitely, M., & Parkin, L. (2026). Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005–2020. Australian and New Zealand Journal of Obstetrics and Gynaecology, 66(3). https://doi.org/10.1111/ajo.70157
Vancouver
Donald S, Sharples K, Barson D, Maclennan K, Te Karu L, Phone D, et al. Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005–2020. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026;66(3). doi:10.1111/ajo.70157
BibTeX
@article{Donald2026,
author = {Donald, Sarah and Sharples, Katrina and Barson, Dave and Maclennan, Karyn and Te Karu, Leanne and Phone, Diana and van Asten, Hedwig and Stitely, Michael and Parkin, Lianne},
title = {Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005–2020},
journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
year = {2026},
volume = {66},
number = {3},
doi = {10.1111/ajo.70157}
}
EUVIMED